News in Brief

Polyskope Labs update on AOAC approval and test launch

By Joseph James Whitworth contact

- Last updated on GMT

Multiplex RT-PCR test kits for detection of pathogens. Picture: Polyskope Labs
Multiplex RT-PCR test kits for detection of pathogens. Picture: Polyskope Labs

Related tags: Thermo fisher scientific, Polymerase chain reaction

Polyskope Labs has signed an agreement with Thermo Fisher Scientific to provide q-PCR technology to customers for free based on minimum orders.

The move comes ahead of a commercial launch and pending AOAC International Performance Tested Method (PTM) approval of the multiplex RT-PCR Polyskope 1.0 test kits for detection of pathogens in food and environmental samples.

It allows Polyskope to place Thermo Fisher Scientific's Applied Biosystems QuantStudio 5 Real-Time PCR systems and reagents in customer labs for use with its kits.

The firm selected the instrument as its platform for launch two years ago.

Polyskope 1.0 kits can detect Shiga Toxin producing E. coli (including serotype O157:H7), Salmonella spp. and Listeria monocytogenes, either individually or simultaneously, using a single RT-PCR protocol and enrichment media after 24 hours.

Co-enrichment of one to three pathogens is done using Polyskope's proprietary Multiplex Enrichment Media (PMEM).

Dr Michael Centola, Polyskope CSO, said QuantStudio is reliable in multiplex assays.

“The instruments have a suite of value-added features for customers, like cloud capability and remote run and analysis. Customers can now remotely run, analyze, and report results for samples processed on the QuantStudio system globally, from any PC, tablet or smart phone,” ​he said.

“This feature is a boon to large testing organizations with multiple satellite labs, as it eliminates the need for highly trained scientists to be present at every facility."

Polyskope completed validation and product testing of the AOAC PTM Independent Lab Study in January and expects to receive certification by April 2018.

The company will begin submissions for international approvals later this year with European availability scheduled mid-2019.

Related news

Show more

Related products

Related suppliers


Post your comment

We will not publish your email address on the website

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.